Drug-eluting Stent: The trial has enrolled a total of 1,832 patients and designed to evaluate the safety and effectiveness of the MagicTouch Sirolimus-Coated Balloon (SCB) in comparison with the ...

Effect of sirolimus on renal injury induced by bile duct ligation in rats 1. Efeito do sirolimo na lesão renal induzida pela ligadura do ducto biliar em ratos. Hulya Ozturk I; Akan Terzi II; Hayrettin ...

Sirolimus is under clinical development by Palvella Therapeutics and currently in Phase III for Lymphoproliferative Disorders. According to GlobalData, Phase III drugs for Lymphoproliferative ...

Background: The impact of incomplete stent apposition (ISA) after drug-eluting stent implantation determined by intravascular ultrasound (IVUS) on late clinical events is not well defined. Objective: ...

Cardiology > PCI Sirolimus Balloons Show Promise in Treating Coronary In-Stent Restenosis — Can this safer drug be delivered reliably to reduce target lesion revascularization?

Sirolimus may be a safe and effective alternative for patients with chronic spontaneous urticaria who do not respond to other treatments, according to a study published in The Journal of Allergy ...

A phase 2, open-label, single-arm, prospective, multicenter study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer. This is an ASCO Meeting Abstract from the ...

NICE is unable to make a recommendation on sirolimus (Hyftor) for treating facial angiofibroma caused by tuberous sclerosis complex in people 6 years and over. This is because Plusultra pharma did not ...